Search Results - Yaning Yang
- Showing 1 - 14 results of 14
-
1
-
2
-
3
-
4
-
5
-
6
The efficacy and safety of chemo‐free therapy in epidermal growth factor receptor tyrosine kinase inhibitor‐resistant advanced non‐small cell lung cancer: A single‐arm, phase II st... by Shuyang Zhang, Lu Yang, Yaning Yang, Guangjian Yang, Haiyan Xu, Xueliang Niu, Yan Wang
Published in Cancer Medicine (2023-10-01)Get full text
Article -
7
Clinical and structural insights into the rare but oncogenic HER2-activating missense mutations in non-small cell lung cancer: a retrospective ATLAS cohort study by Guangjian Yang, Runze Liu, Pei Li, Yaning Yang, Yajie Wang, Huiqing Mao, Xiaoyong Tang
Published in Discover Oncology (2024-07-01)Get full text
Article -
8
Effect of intraoperative low-dose esketamine infusion on postoperative sleep disturbance after laparoscopic cholecystectomy: a randomized clinical trial by Yanan Wu, Yaning Yang, Xiaomei Wang, Li Sun, Yunpeng Hei, Yuhua Zou, Zhenhai Ye, Zhi Yu
Published in BMC Anesthesiology (2025-07-01)Get full text
Article -
9
-
10
Unveiling the role of Pleckstrin-2 in tumor progression and immune modulation: insights from a comprehensive pan-cancer analysis with focus on lung cancer by Enzhi Yin, Chengming Liu, Yuxin Yao, Yuejun Luo, Yaning Yang, Xiaoya Tang, Sufei Zheng, Linyan Tian, Jie He
Published in Molecular Biomedicine (2024-11-01)Get full text
Article -
11
-
12
Challenges of genetic homogeneity in aquaculture of the kelp Saccharina japonica: Insights from China in ten year’s retrospect by Xiaodong Li, Lirong Chang, Feng Han, Xia Li, Luyang Xiao, Ershuai Huang, Yaning Yang, Li Su, Shaojun Pang
Published in Aquaculture Reports (2025-09-01)Get full text
Article -
13
Systematic analysis of IL-6 as a predictive biomarker and desensitizer of immunotherapy responses in patients with non-small cell lung cancer by Chengming Liu, Lu Yang, Haiyan Xu, Sufei Zheng, Zhanyu Wang, Sihui Wang, Yaning Yang, Shuyang Zhang, Xiaoli Feng, Nan Sun, Yan Wang, Jie He
Published in BMC Medicine (2022-05-01)Get full text
Article -
14
Pyrotinib combined with apatinib for targeting metastatic non-small cell lung cancer with HER2 alterations: a prospective, open-label, single-arm phase 2 study (PATHER2) by Guangjian Yang, Haiyan Xu, Yaning Yang, Shuyang Zhang, Fei Xu, Xuezhi Hao, Junling Li, Puyuan Xing, Xingsheng Hu, Yutao Liu, Lin Wang, Lin Lin, Zhijie Wang, Jianchun Duan, Jie Wang, Yan Wang
Published in BMC Medicine (2022-08-01)Get full text
Article
